Tugbainanc (Talk | contribs) |
Tugbainanc (Talk | contribs) |
||
Line 82: | Line 82: | ||
<p> | <p> | ||
− | + | In order to make our gene compatible with RFC 10, 25 and 1000, we reconstructed the nucleotides to get rid of the restriction sites while protecting | |
− | + | the amino acid sequence. We looked through the codon bias property of E. coli and made the nucleotide changes accordingly. | |
− | + | ||
</p> | </p> | ||
− | |||
− | |||
<p> | <p> | ||
− | + | FucO has NADH-dependent furan reductase activity. When furfural is present in the field, the metabolism of furfural by NADPH-dependent oxidoreductases | |
− | + | go active in order to reduce it to its less toxic alcohol derivative-furfuryl alcohol (Zheng, 2013; Wang et al., 2013; Allen et al., 2010). | |
</p> | </p> | ||
− | + | <img src="https://static.igem.org/mediawiki/2018/0/0c/T--METU_HS_Ankara--cparts0121566415.jpg" /> | |
− | <img src="https://static.igem.org/mediawiki/2018/ | + | <i style="font-size: 12px"> |
+ | Figure 2: Effect of FucO overexpression in LY180 (Wang et al., 2011). The Cell Mass was observed in furfural containing medium. The FucO gene expressing | ||
+ | L-1,2-propanediol oxidoreductase reduce the effect of furfural. The specific death rate of normal bacteria is observed to be bigger than the specific | ||
+ | death rate of bacteria with FucO gene. Thus FucO shows to increase the tolerance of bacteria and lifespan. | ||
+ | </i> | ||
<p> | <p> | ||
− | + | In this metabolism, the expression of oxidoreductases that are NADPH-dependent, such as YqhD, are shown to inhibit the growth and fermentation in E. coli | |
− | + | by competing for biosynthesis with NADPH (Zheng, 2013). | |
− | + | ||
− | + | ||
</p> | </p> | ||
− | < | + | <img src="https://static.igem.org/mediawiki/2018/9/9d/T--METU_HS_Ankara--cparts04.jpg" /> |
− | Figure | + | <i style="font-size: 12px"> |
− | + | Figure 3: The overexpression of FucO and YqhD and relationships with furfural resistance traits, metabolism, and reducing cofactors (Wang et al., 2013). | |
− | </ | + | </i> |
<p> | <p> | ||
− | + | Because the native conversion of NADH to NADPH in E. coli is insufficient to revitalize the NADPH pool during fermentation, the actions shouldn’t be | |
− | + | interfering with NADPH metabolism (Wang et al., 2011). Thus, the overexpression of plasmid-based NADH-dependent propanediol oxidoreductase (FucO) gene | |
+ | reduces furfural to ultimately improve furfural resistance without detrimentally affecting the biosynthesis of NADPH (Wang et al., 2011). | ||
</p> | </p> | ||
<img src="https://static.igem.org/mediawiki/2018/b/be/T--METU_HS_Ankara--cparts05.gif" /> | <img src="https://static.igem.org/mediawiki/2018/b/be/T--METU_HS_Ankara--cparts05.gif" /> | ||
− | |||
− | |||
− | < | + | <i style="font-size: 12px"> |
− | + | Figure 4: 3D protein structure of L-1,2-propanediol oxidoreductase | |
− | + | </i> | |
− | + | ||
− | + | ||
− | </ | + | |
− | < | + | <img src="https://static.igem.org/mediawiki/2018/f/f1/T--METU_HS_Ankara--cparts07.jpg" /> |
− | < | + | <i style="font-size: 12px"> |
+ | Figure 5: BBa_K2571003 check with FucO left and VR primers. Expected band length: 754 bp. Last three wells show positive results. | ||
+ | </i> | ||
<p> | <p> | ||
− | + | We’ve inserted the FucO composite part to pSB1C3 and pSB1A3 backbones. Then, we’ve transformed the construct for submission, | |
− | and | + | <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571003">BBa_K2571003</a>, (in pSB1C3) |
− | + | to DH5⍺; and the other construct, for our biochemical assay, (in pSB1A3) to KO11. As we isolated the plasmids, we’ve done PCR with FucO left and VR | |
+ | primers to test orientation of our parts to the backbone. We expected a band of 754 bp between the FucO left and VR primers and the PCR results confirmed | ||
+ | our expectations and showed that our parts were correctly inserted and transformed. | ||
</p> | </p> | ||
<p> | <p> | ||
− | + | VF2 and VR primers are as below: | |
− | + | <br > | |
+ | FucO left: GTGATAAGGATGCCGGAGAA | ||
+ | <br > | ||
+ | VR: ATTACCGCCTTTGAGTGAGC | ||
+ | |||
</p> | </p> | ||
+ | |||
+ | <h3>Composite 2:</h3> | ||
+ | <h4>GSH:Bifunctional gamma-glutamate-cysteine ligase/glutathione synthetase</h4> | ||
<p> | <p> | ||
− | + | Reactive Oxygen Species are dangerous substances that distort protein based matters by taking electrons (Lu, 2013). The chemical structure of the protein-based | |
− | + | substances are altered and become dysfunctional because of ROS (Lu, 2013; Burton & Jauniaux, 2011). | |
− | + | ||
</p> | </p> | ||
<p> | <p> | ||
− | + | Furthermore, one of the most significant protein-based substance, DNA get attacked by OH radicals (Burton & Jauniaux, 2011). However, the reduced form GSH can protect | |
− | + | the chemical structure of the proteins by giving extra electrons to the ROS and free radicals (Lu, 2013). This is accomplished by GSH peroxidase-catalyzed reactions | |
+ | (Lu, 2013). | ||
</p> | </p> | ||
+ | |||
+ | <img src="https://2018.igem.org/File:T--METU_HS_Ankara--cparts0121566.jpg" /> | ||
<img src="https://static.igem.org/mediawiki/2018/c/cd/T--METU_HS_Ankara--cparts08.gif" /> | <img src="https://static.igem.org/mediawiki/2018/c/cd/T--METU_HS_Ankara--cparts08.gif" /> | ||
+ | |||
+ | <i style="font-size: 12px"> | ||
+ | Figure 6: 3D protein structure of Bifunctional gamma-glutamate-cysteine ligase | ||
+ | </i> | ||
<h5>Our circuit design for GSH gene</h5> | <h5>Our circuit design for GSH gene</h5> | ||
<p> | <p> | ||
− | Our circuit consists of prefix, a strong promoter (J23100), RBS (B0034), GSH as | + | Our circuit consists of prefix, a strong promoter (J23100), RBS (B0034), GSH as protein coding region, double terminator (B0015) and suffix. This part enables our E. |
− | + | coli KO11 strain to overexpress oxidised Glutathione to reduce oxidative stress, increasing its lifespan. (Lu, 2013) Our construct is inserted into pSB1C3 and | |
− | + | delivered to the Registry. | |
</p> | </p> | ||
<img src="https://static.igem.org/mediawiki/2018/b/b4/T--METU_HS_Ankara--cparts09.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/b/b4/T--METU_HS_Ankara--cparts09.jpg" /> | ||
− | < | + | <i style="font-size: 12px"> |
+ | Figure 7: Circuit design of Composite part 2 with GSH gene. <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">BBa_K2571005</a>. Our construct | ||
+ | includes a strong promoter, RBS, GSH and double terminator. | ||
+ | </i> | ||
− | < | + | <p> |
+ | In order to make our gene compatible with RFC 10, 25 and 1000, we reconstructed the nucleotides to get rid of the restriction sites while protecting the amino acid | ||
+ | sequence. We looked through the codon bias property of E.coli and made the nucleotide changes accordingly. | ||
+ | </p> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2018/8/87/T--METU_HS_Ankara--cparts012566.jpg" /> | ||
+ | <i style="font-size: 12px"> | ||
+ | Figure 8: Because Glutathione prevents the ROS from harming the bacteria, in high glutathione concentration increase in cell mass was observed. In brief, when | ||
+ | glutathione concentration increases, the specific cell growth rate also increases and we observe increase in number of bacteria compared to the bacteria without | ||
+ | GSH gene (Kim & Hahn , 2013). | ||
+ | </i> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2018/9/9d/T--METU_HS_Ankara--cparts01256eeie6.jpg" /> | ||
+ | |||
+ | <i style="font-size: 12px"> | ||
+ | Figure 9: <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">BBa_K2571005</a> check with GSH specific primers. Expected band length: 225 bp. | ||
+ | Last six wells show positive results. | ||
+ | </i> | ||
<p> | <p> | ||
Line 170: | Line 202: | ||
to Dh4 alpha and conducted colony PCR. We’ve made the PCR with GSH specific primers and expected to see a result of 225bp. By showing the | to Dh4 alpha and conducted colony PCR. We’ve made the PCR with GSH specific primers and expected to see a result of 225bp. By showing the | ||
band we expected, 225bp, PCR confirmation for our insertion proved right. | band we expected, 225bp, PCR confirmation for our insertion proved right. | ||
+ | </p> | ||
+ | |||
+ | <p> | ||
+ | GSH left and right primers are shown as below: | ||
+ | <br > | ||
+ | GSH left: TCGGAGGCTAAAACTCAGGA | ||
+ | <br > | ||
+ | GSH right: GTGGGCAGTCCAGTCGTAAT | ||
</p> | </p> | ||
Line 187: | Line 227: | ||
</p> | </p> | ||
− | <h4>Design Notes of Dual Expression of FucO and GSH</h4> | + | <h4>Design Notes of Dual Expression of FucO and GSH <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571006">(BBa_K2571006)</a></h4> |
<p> | <p> | ||
− | Our construct for composite part 3 is composed of two stages, first the reduction of furans (specifically furfural and 5-HMF) and second | + | Our construct for composite part 3 is composed of two stages, first the reduction of furans (specifically furfural and 5-HMF) and second the |
− | + | detoxification of reactive oxygen species (ROS).-To achieve this effect, we designed our composite 3 part as with a prefix, a strong promoter | |
− | + | (J23100), RBS (B0034), fucO as the first protein coding region <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571003">(BBa_K2571003)</a>, | |
− | + | RBS (B0034), GSH as the second protein coding region <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">(BBa_K2571005)</a>, | |
+ | double terminator (B0015) and suffix. | ||
</p> | </p> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2018/d/dc/T--METU_HS_Ankara--cparts01256eie6.jpg" /> | ||
+ | |||
+ | <i style="font-size: 12px"> | ||
+ | Figure 10: Circuit design of Composite part 3 with FucO and GSH genes. <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571006">BBa_K2571006</a>. | ||
+ | Our construct includes a strong promoter, RBS, FucO, RBS, GSH and double terminator. | ||
+ | </i> | ||
<p> | <p> | ||
− | + | Our construct is inserted into pSB1C3 and delivered to the Registry. Our construct is also inserted into pSB1A3 and transferred into KO11 to | |
− | + | conduct further biochemical assays. | |
− | + | ||
− | + | ||
</p> | </p> | ||
+ | |||
+ | <p> | ||
+ | Given that fucO is NADH-dependent it outperforms other oxidoreductases, by not interfering with the NADPH metabolism of the organism while converting highly | ||
+ | toxic substances, furfural and 5-HMF to non-harmful alcohols. This characteristic of fucO is crucial because the expression of oxidoreductases like Yqhd are | ||
+ | NADPH-dependent, hence they compete with the biosynthesis for NADPH, which results in inhibiting the growth of the organism. | ||
+ | </p> | ||
+ | |||
+ | <p> | ||
+ | Glutathione, on the other hand, is recycled using NAD(P)H pathways and since now it will be overexpressed and with NADH metabolism is not being altered thanks | ||
+ | to FucO, antioxidant capacity of the cell will be increased dramatically, result in amplified immunity to both furans and ROS, habilitating cell growth, | ||
+ | increasing ethanol yield by the virtue of increasing cell mass and reproduction, and improved metabolism. | ||
+ | </p> | ||
+ | |||
<section class="ct-u-paddingTop50 ct-u-paddingBottom80 ct-u-borderBoth ct-u-backgroundGray"> | <section class="ct-u-paddingTop50 ct-u-paddingBottom80 ct-u-borderBoth ct-u-backgroundGray"> | ||
Line 218: | Line 277: | ||
<div id="collapseOne" class="panel-collapse collapse"> | <div id="collapseOne" class="panel-collapse collapse"> | ||
<div class="panel-body"> | <div class="panel-body"> | ||
− | Allen, S. A., Clark, W., McCaffery, J. M., Cai, Z., Lanctot, A., Slininger, P. J., … Gorsich, S. W. (2010). | + | <ul> |
− | + | <li> | |
− | + | Allen, S. A., Clark, W., McCaffery, J. M., Cai, Z., Lanctot, A., Slininger, P. J., … Gorsich, S. W. (2010). | |
+ | Furfural induces reactive oxygen species accumulation and cellular damage in Saccharomyces cerevisiae. | ||
+ | Biotechnology for Biofuels, 3, 2. http://doi.org/10.1186/1754-6834-3-2 | ||
+ | </li> | ||
+ | </ul> | ||
+ | |||
</div> | </div> | ||
</div> | </div> |
Revision as of 11:56, 1 October 2018